Clinical trial
A Study of Debio 1347 Plus Fulvestrant in Patients With Metastatic Breast Cancer
NCT03344536
Study timeline
Study start (actual)2017-11-10Date precision: day
Registry last updated2022-11-25
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
FulvestrantDRUG · verified · RxNorm: fulvestrant
Debio 1347DRUG
Sponsors & collaborators
Memorial Sloan Kettering Cancer Centerlead sponsor
Debiopharm International SAcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03344536 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.